Buscar
01/02/2022
Fluid markers of synapse degeneration in synucleinopathies
Gonzalez, AC, Belbin, O. Fluid markers of synapse degeneration in synucleinopathies. JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02467-8. PMID:35147800. IF:3.300(Q2/5D).
01/02/2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Delaby, C, Alcolea, D, Hirtz, C, Vialaret, J, Kindermans, J, Morichon, L, Fortea, J, Belbin, O, Gabelle, A, Blennow, K, Zetterberg, H, Lleo, A, Lehmann, S. Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles. JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02474-9. PMID:35169889. IF:3.300(Q2/5D).
01/02/2022
The A beta 1-42/A beta 1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A beta 1-42 alone
Delaby, C, Estelles, T, Zhu, NU, Arranz, J, Barroeta, I, Carmona-Iragui, M, Illan-Gala, I, Santos-Santos, MA, Altuna, M, Sala, I, Sanchez-Saudinos, MB, Videla, L, Valldeneu, S, Subirana, A, Tondo, M, Blanco-Vaca, F, Lehmann, S, Belbin, O, Blesa, R, Fortea, J, Lleo, A, Alcolea, D. The A beta 1-42/A beta 1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than A beta 1-42 alone. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-00967-z. PMID:35105351. IF:9.000(Q1/1D).
01/02/2022
Proteinopathies: molecular mechanisms and diagnostic perspectives (vol 129, pg 129, 2022)
Delaby, C, Lehmann, S. Proteinopathies: molecular mechanisms and diagnostic perspectives (vol 129, pg 129, 2022). JOURNAL OF NEURAL TRANSMISSION. 2022; 129(2)DOI:10.1007/s00702-022-02473-w. PMID:35175386. IF:3.300(Q2/5D).
18/01/2022
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
Reyes-Leiva, D, Dols-Icardo, O, Sirisi, S, Cortes-Vicente, E, Turon-Sans, J, De Luna, N, Blesa, R, Belbin, O, Montal, V, Alcolea, D, Fortea, J, Lleo, A, Rojas-Garcia, R, Illan-Gala, I. Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies. Frontiers in Neurology. 2022; 12DOI:10.3389/fneur.2021.750543. PMID:35115992. IF:3.400(Q2/5D).
01/01/2022
Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study
Padilla, C, Montal, V, Walpert, MJ, Hong, YT, Fryer, TD, Coles, JP, Aigbirhio, FI, Hartley, SL, Cohen, AD, Tudorascu, DL, Christian, BT, Handen, BL, Klunk, WE, Holland, AJ, Zaman, SH. Cortical atrophy and amyloid and tau deposition in Down syndrome: A longitudinal study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2022; 14(1)DOI:10.1002/dad2.12288. PMID:35386472. IF:(Q/D).
02/11/2022
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients
Lennol, MP, Sanchez-Dominguez, I, Cuchillo-Ibanez, I, Camporesi, E, Brinkmalm, G, Alcolea, D, Fortea, J, Lleo, A, Soria, G, Aguado, F, Zetterberg, H, Blennow, K, Saez-Valero, J. Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01108-2. PMID:36324176. IF:9.000(Q1/1D).
01/11/2022
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
Jansen, RE, van der Lee, SJ, Gomez-Fonseca, D, de Rojas, I, Dalmasso, MC, Grenier-Boley, B, Zettergren, A, Mishra, A, Ali, M, Andrade, V, Bellenguez, C, Kleineidam, L, Kucukali, F, Sung, YJ, Tesi, N, Vromen, EM, Wightman, DP, Alcolea, D, Alegret, M, Alvarez, I, Amouyel, P, Athanasiu, L, Bahrami, S, Bailly, H, Belbin, O, Bergh, S, Bertram, L, Biessels, GJ, Blennow, K, Blesa, R, Boada, M, Boland, A, Buerger, K, Carracedo, A, Cervera-Carles, L, Chene, G, Claassen, JAHR, Debette, S, Deleuze, JF, de Deyn, PP, Diehl-Schmid, J, Djurovic, S, Dols-Icardo, O, Dufouil, C, Duron, E, Duzel, E, Fladby, T, Fortea, J, Frolich, L, Garcia-Gonzalez, P, Garcia-Martinez, M, Giegling, I, Goldhardt, O, Gobom, J, Grimmer, T, Haapasalo, A, Hampel, H, Hanon, O, Hausner, L, Heilmann-Heimbach, S, Helisalmi, S, Heneka, MT, Hernandez, I, Herukka, SK, Holstege, H, Jarholm, J, Kern, S, Knapskog, AB, Koivisto, AM, Kornhuber, J, Kuulasmaa, T, Lage, C, Laske, C, Leinonen, V, Lewczuk, P, Lleo, A, de Munain, AL, Lopez-Garcia, S, Maier, W, Marquie, M, Mol, MO, Montrreal, L, Moreno, F, Moreno-Grau, S, Nicolas, G, Nothen, MM, Orellana, A, Palhaugen, L, Papma, JM, Pasquier, F, Perneczky, R, Peters, O, Pijnenburg, YAL, Popp, J, Posthuma, D, Pozueta, A, Priller, J, Puerta, R, Quintela, I, Ramakers, I, Rodriguez-Rodriguez, E, Rujescu, D, Saltvedt, I, Sanchez-Juan, P, Scheltens, P, Scherbaum, N, Schmid, M, Schneider, A, Selbaek, G, Selnes, P, Shadrin, A, Skoog, I, Soininen, H, Tarraga, L, Teipel, S, Tijms, B, Tsolaki, M, Van Broeckhoven, C, Van Dongen, J, van Swieten, JC, Vandenberghe, R, Vidal, JS, Visser, PJ, Vogelgsang, J, Waern, M, Wagner, M, Wiltfang, J, Wittens, MMJ, Zetterberg, H, Zulaica, M, van Duijn, CM, Bjerke, M, Engelborghs, S, Jessen, F, Teunissen, CE, Pastor, P, Hiltunen, M, Ingelsson, M, Andreassen, OA, Clarimon, J, Sleegers, K, Ruiz, A, Ramirez, A, Cruchaga, C, Lambert, JC, van der Flier, W. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers. ACTA NEUROPATHOLOGICA. 2022; 144(5)DOI:10.1007/s00401-022-02454-z. PMID:36066633. IF:12.700(Q1/1D).
01/10/2022
The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary
Hampel, H, Elhage, A, Shaw, LM, Aisen, P, Chen, C, Lleo, A, Iwatsubo, T, Iwata, A, Yamada, M, Ikeuchi, T, Jia, JP, Wang, HL, Teunissen, CE, Peskind, E, Blennow, K, Cummings, J, Vergallo, A. The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summary. Neurodegenerative Disease Management. 2022; 12(5)DOI:10.2217/nmt-2022-0012. PMID:35866715. IF:(Q/D).
01/10/2022
Myelin loss in C9orf72 hexanucleotide expansion carriers
Sirisi, S, Querol-Vilaseca, M, Dols-Icardo, O, Pegueroles, J, Montal, V, Munoz, L, Torres, S, Ferrer-Raventos, P, Iulita, MF, Sanchez-Aced, E, Blesa, R, Illan-Gala, I, Molina-Porcel, L, Borrego-Ecija, S, Sanchez-Valle, R, Clarimon, J, Belbin, O, Fortea, J, Lleo, A. Myelin loss in C9orf72 hexanucleotide expansion carriers. JOURNAL OF NEUROSCIENCE RESEARCH. 2022; 100(10)DOI:10.1002/jnr.25100. PMID:35766328. IF:4.200(Q2/4D).
06/09/2022
Early Motor Changes in Genetic Frontotemporal Dementia
Lleo, A, Illan-Gala, I. Early Motor Changes in Genetic Frontotemporal Dementia. NEUROLOGY. 2022; 99(10)DOI:10.1212/WNL.0000000000200967. PMID:36219793. IF:9.900(Q1/1D).
03/09/2022
Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease
Benejam, B, Aranha, MR, Videla, L, Padilla, C, Valldeneu, S, Fernandez, S, Altuna, M, Carmona-Iragui, M, Barroeta, I, Iulita, MF, Montal, V, Pegueroles, J, Bejanin, A, Gimenez, S, Gonzalez-Ortiz, S, Videla, S, Bartres-Faz, D, Alcolea, D, Blesa, R, Lleo, A, Fortea, J. Neural correlates of episodic memory in adults with Down syndrome and Alzheimer's disease. Alzheimers Research & Therapy. 2022; 14(1)DOI:10.1186/s13195-022-01064-x. PMID:36057615. IF:9.000(Q1/1D).
01/09/2022
Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain
Villarejo-Galende, A, Garcia-Arcelay, E, Pinol-Ripoll, G, del Olmo-Rodriguez, A, Vinuela, F, Boada, M, Franco-Macias, E, de la Pena, AI, Riverol, M, Puig-Pijoan, A, Abizanda-Soler, P, Arroyo, R, Baquero-Toledo, M, Feria-Vilar, I, Balasa, M, Berbel, A, Rodriguez-Rodriguez, E, Vieira-Campos, A, Garcia-Ribas, G, Rodrigo-Herrero, S, Lleo, A, Maurino, J. Awareness of Diagnosis in Persons with Early-Stage Alzheimer's Disease: An Observational Study in Spain. Neurology and Therapy. 2022; 11(3)DOI:10.1007/s40120-022-00367-3. PMID:35648383. IF:3.700(Q2/4D).
01/09/2022
Intermediate and Expanded HTT Alleles and the Risk for alpha-Synucleinopathies
Perez-Oliveira, S, Alvarez, I, Rosas, I, Menendez-Gonzalez, M, Blazquez-Estrada, M, Aguilar, M, Corte, D, Buongiorno, M, Molina-Porcel, L, Aldecoa, I, Marti, MJ, Sanchez-Juan, P, Infante, J, Gonzalez-Aramburu, I, Garcia-Gonzalez, P, Rosende-Roca, M, Boada, M, Ruiz, A, Perinan, MT, Macias-Garcia, D, Munoz-Delgado, L, Gomez-Garre, P, Mir, P, Clarimon, J, Lleo, A, Alcolea, D, De la Casa-Fages, B, Duarte, I, Alvarez, V, Pastor, P. Intermediate and Expanded HTT Alleles and the Risk for alpha-Synucleinopathies. MOVEMENT DISORDERS. 2022; 37(9)DOI:10.1002/mds.29153. PMID:35852957. IF:8.600(Q1/1D).
05/08/2022
Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome
Videla, L, Benejam, B, Pegueroles, J, Carmona-Iragui, M, Padilla, C, Fernandez, S, Barroeta, I, Altuna, M, Valldeneu, S, Garzon, D, Ribas, L, Montal, V, Martinez, JA, Aranha, MR, Alcolea, D, Bejanin, A, Iulita, MF, Ces, SV, Blesa, R, Lleo, A, Fortea, J. Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome. JAMA Network Open. 2022; 5(8)DOI:10.1001/jamanetworkopen.2022.25573. PMID:35930282. IF:13.800(Q1/1D).
01/08/2022
HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis
Borras, C, Mercer, A, Sirisi, S, Alcolea, D, Escola-Gil, JC, Blanco-Vaca, F, Tondo, M. HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer's Disease Pathogenesis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(16)DOI:10.3390/ijms23169356. PMID:36012637. IF:5.600(Q1/3D).
27/07/2022
Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes
Montal, V, Diez, I, Kim, CM, Orwig, W, Bueicheku, E, Gutierrez-Zuniga, R, Bejanin, A, Pegueroles, J, Dols-Icardo, O, Vannini, P, El-Fakhri, G, Johnson, KA, Sperling, RA, Fortea, J, Sepulcre, J. Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes. Science Translational Medicine. 2022; 14(655)DOI:10.1126/scitranslmed.abn7273. PMID:35895837. IF:17.100(Q1/1D).
01/07/2022
Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
Orellana, A, Garcia-Gonzalez, P, Valero, S, Montrreal, L, de Rojas, I, Hernandez, I, Rosende-Roca, M, Vargas, L, Tartari, JP, Antonio, EED, Bojaryn, U, Narvaiza, L, Alarcon-Martin, E, Alegret, M, Alcolea, D, Lleo, A, Tarraga, L, Pytel, V, Cano, A, Marquie, M, Boada, M, Ruiz, A. Establishing In-House Cutoffs of CSF Alzheimer's Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(13)DOI:10.3390/ijms23136891. PMID:35805894. IF:5.600(Q1/3D).
14/06/2022
Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease
Aranha, MR, Fortea, J, Carmona-Iragui, M. Cerebral Amyloid Angiopathy-Related Inflammation in Down Syndrome-Related Alzheimer Disease. NEUROLOGY. 2022; 98(24)DOI:10.1212/WNL.0000000000200704. PMID:35470138. IF:9.900(Q1/1D).
03/06/2022
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K, Shah, Z, Chia, R, Scholz, SW, Alcolea, D., Clarimón, J., Fortea, J., Lleó, A., Int LBD Genomics Consortium. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups. BRAIN. 2022; 145(5)DOI:10.1093/brain/awab402. PMID:35381062. IF:14.500(Q1/1D).